TELA Bio, Inc. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
TELA Bio, Inc. (TELA) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $8.70 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-03-25
- TELA Bio, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $8.70M, a 52.63% increase from fiscal 2024.
- TELA Bio, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $5.70M, a 47.71% decline from fiscal 2023.
- TELA Bio, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $10.90M, a 4.81% increase from fiscal 2022.
- TELA Bio, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $10.40M, a 28.40% increase from fiscal 2021.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|
| 2025-12-31 | $8.70M 10-K · filed 2026-03-25 |
| 2024-12-31 | $5.70M 10-K · filed 2026-03-25 |
| 2023-12-31 | $10.90M 10-K · filed 2025-03-21 |
| 2022-12-31 | $10.40M 10-K · filed 2024-03-22 |
| 2021-12-31 | $8.10M 10-K · filed 2023-03-23 |
| 2020-12-31 | $6.90M 10-K · filed 2022-03-23 |
| 2019-12-31 | $5.40M 10-K · filed 2021-03-25 |
| 2018-12-31 | $5.50M 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| InspireMD, Inc. (NSPR) | $0.033B |